Magnetoliposomes in Controlled-Release Drug Delivery Systems

Overview

Journal Crit Rev Biomed Eng

Publisher Begell House

Specialty Biomedical Engineering

Date 2020 May 19

PMID 32421974

Citations 3

Authors

Asahi Tomitaka

Yasushi Takemura

Zaohua Huang

Upal Roy

Madhavan Nair

Affiliations

Soon will be listed here.

Abstract

Liposomes, one of the most promising drug delivery carriers, have been extensively studied for the treatment of various diseases and have made their way to the market. Magnetic nanoparticles have been attracting great interest for diagnostic and therapeutic applications due to their unique magnetic properties. An integration of liposomes and magnetic nanoparticles gives great potential to the field of smart drug delivery systems, including magnetically guided drug delivery, image-guided drug delivery, and externally triggered controlled drug release using hyperthermia or alternating magnetic fields. In this review, we discuss the recent development of magnetoliposomes for controlled-release drug delivery systems and their potential.

Citing Articles

Navigating the Clinical Landscape of Liposomal Therapeutics in Cancer Treatment.

Kozak A, Lavrih E, Mikhaylov G, Turk B, Vasiljeva O Pharmaceutics. 2025; 17(2).

PMID: 40006643 PMC: 11859495. DOI: 10.3390/pharmaceutics17020276.

Development and Characterization of Magnetic Nanoemulsion-Based Senolytic Peptides for Osteoarthritis Treatment.

Zara-Danceanu C, Garcia-Fernandez J, Herea D, Gherca D, de Francisco Carrera I, Labusca L Int J Mol Sci. 2025; 26(3).

PMID: 39941060 PMC: 11818740. DOI: 10.3390/ijms26031292.

Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.

Wang M, Xue W, Yuan H, Wang Z, Yu L Int J Nanomedicine. 2024; 19:2823-2849.

PMID: 38525013 PMC: 10959015. DOI: 10.2147/IJN.S451151.

LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy.

Cepero A, Jimenez-Carretero M, Jabalera Y, Gago L, Luque C, Cabeza L Int J Nanomedicine. 2024; 19:1843-1865.

PMID: 38414530 PMC: 10898605. DOI: 10.2147/IJN.S440881.

Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy.

Luiz M, Dutra J, Viegas J, de Araujo J, Junior A, Chorilli M Pharmaceutics. 2023; 15(3).

PMID: 36986612 PMC: 10058222. DOI: 10.3390/pharmaceutics15030751.

References

Han X, Li Z, Sun J, Luo C, Li L, Liu Y . Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. J Control Release. 2014; 197:29-40. DOI: 10.1016/j.jconrel.2014.10.024. View

Wang X, Yang R, Yuan C, An Y, Tang Q, Chen D . Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo. Target Oncol. 2018; 13(4):481-494. DOI: 10.1007/s11523-018-0577-y. View

Li N, Peng L, Chen X, Nakagawa S, Gao J . Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo. Int J Nanomedicine. 2012; 6:3241-50. PMC: 3252672. DOI: 10.2147/IJN.S26152. View

Yatvin M, Weinstein J, DENNIS W, Blumenthal R . Design of liposomes for enhanced local release of drugs by hyperthermia. Science. 1978; 202(4374):1290-3. DOI: 10.1126/science.364652. View

Ito A, Fujioka M, Yoshida T, Wakamatsu K, Ito S, Yamashita T . 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci. 2007; 98(3):424-30. PMC: 11159801. DOI: 10.1111/j.1349-7006.2006.00382.x. View

Barenholz Y . Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012; 160(2):117-34. DOI: 10.1016/j.jconrel.2012.03.020. View

Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Doblinger M . Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release. 2009; 142(1):108-21. DOI: 10.1016/j.jconrel.2009.10.002. View

Lu A, Schmidt W, Matoussevitch N, Bonnemann H, Spliethoff B, Tesche B . Nanoengineering of a magnetically separable hydrogenation catalyst. Angew Chem Int Ed Engl. 2004; 43(33):4303-6. DOI: 10.1002/anie.200454222. View

Nair M, Guduru R, Liang P, Hong J, Sagar V, Khizroev S . Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers. Nat Commun. 2013; 4:1707. DOI: 10.1038/ncomms2717. View

10.

Wang L, Zhang J, An Y, Wang Z, Liu J, Li Y . A study on the thermochemotherapy effect of nanosized As2O3/MZF thermosensitive magnetoliposomes on experimental hepatoma in vitro and in vivo. Nanotechnology. 2011; 22(31):315102. DOI: 10.1088/0957-4484/22/31/315102. View

11.

Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View

12.

Bothun G, Lelis A, Chen Y, Scully K, Anderson L, Stoner M . Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomedicine. 2011; 7(6):797-805. PMC: 3167980. DOI: 10.1016/j.nano.2011.02.007. View

13.

Liang S, Wang Y, Yu J, Zhang C, Xia J, Yin D . Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J Mater Sci Mater Med. 2007; 18(12):2297-302. DOI: 10.1007/s10856-007-3130-6. View

14.

Bealle G, Di Corato R, Kolosnjaj-Tabi J, Dupuis V, Clement O, Gazeau F . Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia. Langmuir. 2012; 28(32):11834-42. DOI: 10.1021/la3024716. View

15.

Qiu D, An X . Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. Colloids Surf B Biointerfaces. 2013; 104:326-9. DOI: 10.1016/j.colsurfb.2012.11.033. View

16.

Hyeon T, Lee S, Park J, Chung Y, Na H . Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc. 2001; 123(51):12798-801. DOI: 10.1021/ja016812s. View

17.

Maeda H, Bharate G, Daruwalla J . Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2008; 71(3):409-19. DOI: 10.1016/j.ejpb.2008.11.010. View

18.

Garcia Ribeiro R, Gysemans C, da Cunha J, Manshian B, Jirak D, Kriz J . Magnetoliposomes as Contrast Agents for Longitudinal in vivo Assessment of Transplanted Pancreatic Islets in a Diabetic Rat Model. Sci Rep. 2018; 8(1):11487. PMC: 6068133. DOI: 10.1038/s41598-018-29136-9. View

19.

Viroonchatapan E, Sato H, Ueno M, Adachi I, Tazawa K, HORIKOSHI I . Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system. Life Sci. 1996; 58(24):2251-61. DOI: 10.1016/0024-3205(96)00220-2. View

20.

Tong S, Quinto C, Zhang L, Mohindra P, Bao G . Size-Dependent Heating of Magnetic Iron Oxide Nanoparticles. ACS Nano. 2017; 11(7):6808-6816. DOI: 10.1021/acsnano.7b01762. View